n-acetylamrinone has been researched along with Thrombopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, S; Handa, S; Hoshiba, Y; Ikeda, Y; Kumagai, A; Sadiq, A; Tamura, N; Tanabe, T; Yoshida, M | 1 |
Allen-Webb, EM; McGough, EC; Pappas, JB; Ross, MP | 1 |
2 other study(ies) available for n-acetylamrinone and Thrombopenia
Article | Year |
---|---|
Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Amrinone; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Imidazoles; In Vitro Techniques; Phosphodiesterase Inhibitors; Platelet Aggregation; Pyridones; Stress, Mechanical; Thrombocytopenia | 2003 |
Amrinone-associated thrombocytopenia: pharmacokinetic analysis.
Topics: Amrinone; Child; Child, Preschool; Humans; Infant; Metabolic Clearance Rate; Platelet Count; Risk Factors; Thrombocytopenia | 1993 |